The optogenetic promise for oncology: Episode I

Alvaro Ingles-Prieto; Eva Reichhart; Karin Schelch; Harald Janovjak; Michael Grusch

doi:10.4161/23723548.2014.964045

The optogenetic promise for oncology: Episode I

Alvaro Ingles-Prieto, Eva Reichhart, Karin Schelch, Harald Janovjak, Michael Grusch

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

18 Downloads (Pure)

Abstract

As light-based control of fundamental signaling pathways is becoming a reality, the field of optogenetics is rapidly moving beyond neuroscience. We have recently developed receptor tyrosine kinases that are activated by light and control cell proliferation, epithelial–mesenchymal transition, and angiogenic sprouting—cell behaviors central to cancer progression.

Original language	English
Article number	e964045
Number of pages	4
Journal	Molecular and Cellular Oncology
Volume	1
Issue number	4
DOIs	https://doi.org/10.4161/23723548.2014.964045
Publication status	Published - 2014
Externally published	Yes

Keywords

hallmarks of cancer
Optogenetics
receptor tyrosine kinase
spatio-temporal control
synthetic physiology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.4161/23723548.2014.964045Licence: CC BY-NC

Ingles-Prieto_Optogentic_P2014Final published version, 1.72 MBLicence: CC BY-NC

Cite this

@article{35c0a64e9b28462c9ede99baca2fcf44,

title = "The optogenetic promise for oncology: Episode I",

abstract = "As light-based control of fundamental signaling pathways is becoming a reality, the field of optogenetics is rapidly moving beyond neuroscience. We have recently developed receptor tyrosine kinases that are activated by light and control cell proliferation, epithelial–mesenchymal transition, and angiogenic sprouting—cell behaviors central to cancer progression.",

keywords = "hallmarks of cancer, Optogenetics, receptor tyrosine kinase, spatio-temporal control, synthetic physiology",

author = "Alvaro Ingles-Prieto and Eva Reichhart and Karin Schelch and Harald Janovjak and Michael Grusch",

year = "2014",

doi = "10.4161/23723548.2014.964045",

language = "English",

volume = "1",

journal = "Molecular and Cellular Oncology",

issn = "2372-3556",

publisher = "Taylor & Francis",

number = "4",

}

TY - JOUR

T1 - The optogenetic promise for oncology

T2 - Episode I

AU - Ingles-Prieto, Alvaro

AU - Reichhart, Eva

AU - Schelch, Karin

AU - Janovjak, Harald

AU - Grusch, Michael

PY - 2014

Y1 - 2014

N2 - As light-based control of fundamental signaling pathways is becoming a reality, the field of optogenetics is rapidly moving beyond neuroscience. We have recently developed receptor tyrosine kinases that are activated by light and control cell proliferation, epithelial–mesenchymal transition, and angiogenic sprouting—cell behaviors central to cancer progression.

AB - As light-based control of fundamental signaling pathways is becoming a reality, the field of optogenetics is rapidly moving beyond neuroscience. We have recently developed receptor tyrosine kinases that are activated by light and control cell proliferation, epithelial–mesenchymal transition, and angiogenic sprouting—cell behaviors central to cancer progression.

KW - hallmarks of cancer

KW - Optogenetics

KW - receptor tyrosine kinase

KW - spatio-temporal control

KW - synthetic physiology

UR - http://www.scopus.com/inward/record.url?scp=85020597394&partnerID=8YFLogxK

U2 - 10.4161/23723548.2014.964045

DO - 10.4161/23723548.2014.964045

M3 - Article

AN - SCOPUS:85020597394

SN - 2372-3556

VL - 1

JO - Molecular and Cellular Oncology

JF - Molecular and Cellular Oncology

IS - 4

M1 - e964045

ER -

The optogenetic promise for oncology: Episode I

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this